Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine adjunctive therapy added to clozapine in refractory schizophrenia
ISRCTN14760638Phase 2Completed
- Sponsor
- GGZ Noord-Holland Noord
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of memantine in schizophrenia (3 arms), sponsored by GGZ Noord-Holland Noord. Primary endpoints: Cognitive functioning, Severity of psychopathology and 1 more. Started Aug 2013; status: completed.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ISRCTN14760638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14760638.